Audrey Brussel, PhD LFB

Audrey joined 2 years ago the Corporate Biological Safety Unit of LFB for promoting operational excellence and continuous improvement in pathogen safety. She specifically brings her expertise to LFB biotechnology affiliates which are manufacturing a variety of products including monoclonal antibodies, cell and gene therapies and recombinant proteins produced from transgenic animals.

Audrey previously worked for 8 years at Sanofi. During this period, Audrey defined policies and led the implementation of best practices during drug development to insure TSE & Virus safety of Sanofi products. In particular, she led efforts for the evaluation of NGS and of media treatment options. Prior to that, Audrey was virus clearance study director at Texcell, a CRO specialized in Virus safety.

Audrey received her PhD in Virology/Genetics from the Paris VI University and she was a post doctoral fellow at Institut Pasteur of Paris, in Virology.